As the human cannabinoid (CBD) market grows, there is an inevitable transfer of the same or similar products into the veterinary sector. Advances in veterinary medicine and care of companion animals has led to extended life expectancy and consequently, there is an increased incidence of age-related chronic conditions that compromise quality of life. CBD products may alleviate these conditions. Research into CBD for companion animal species is on the rise, however, we found that there are no licensed veterinary CBD products available in the market due to a lack of appropriate testing and/or data. Here we outline the data that is available and show that the regulatory, and safety considerations around these products needs further consideration and this encompasses many products currently available on the market. Changes in regulations and further research for quality assurance are paramount to distribution of safe and applicable products for companion animals.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1186/s42238-024-00257-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Preparation of magnetic rice husk carbon nanocomposite for efficiently extracting aflatoxin B1 from rice followed by time-resolved fluorescent immunochromatographic assay.
Food Chem X
January 2025
Food Processing Research Institute, Heilongjiang Academy of Agricultural Sciences, Harbin 150086, China.
An on-site, sensitive, and cost-effective method for determining aflatoxin B1 (AFB1) in rice samples is proposed, combining magnetic solid phase extraction (MSPE) and time-resolved fluorescence immunochromatography (TRFICA) techniques. Cost-effective rice husks were carbonized and combined with nanomaterials to make magnetic nanocomposites that acted as effective adsorbents in MSPE. Under optimal conditions, the entire process was completed in 15 min with a visual detection limit of 0.
View Article and Find Full Text PDFCBD for pets: navigating quality assurance, safety standards, and marketing strategies.
J Cannabis Res
January 2025
vHive, School of Veterinary Medicine, University of Surrey, Guildford, GU2 7AL, UK.
As the human cannabinoid (CBD) market grows, there is an inevitable transfer of the same or similar products into the veterinary sector. Advances in veterinary medicine and care of companion animals has led to extended life expectancy and consequently, there is an increased incidence of age-related chronic conditions that compromise quality of life. CBD products may alleviate these conditions.
View Article and Find Full Text PDFOral cannabidiol did not impair learning and memory in healthy adults.
J Cannabis Res
January 2025
Department of Biology, Colorado State University Pueblo, 2200 Bonforte Blvd, Pueblo, CO, 81001, USA.
Background: The effect of oral Cannabidiol (CBD) on interference during learning and memory (L&M) in healthy human volunteers has not been studied.
Method: A two-arm crossover, randomized, double-blind, placebo-controlled trial was conducted at Colorado State University Pueblo (CSU Pueblo) to evaluate the effects of 246 mg oral CBD on L&M in healthy adults. Among 57 healthy volunteers enrolled, 35 were included in the analyses.
Evaluating the impact of ESICM 2023 guidelines and the new global definition of ARDS on clinical outcomes: insights from MIMIC-IV cohort data.
Eur J Med Res
January 2025
The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, Fujian, China.
Background: In 2023, the European Society of Intensive Care Medicine (ESICM) recommended updated criteria for acute respiratory distress syndrome (ARDS). In 2024, Matthay et al. updated the global ARDS definition in AJRCCM, titled "A New Global Definition of Acute Respiratory Distress Syndrome.
View Article and Find Full Text PDFAssessing paediatric blood culture quality: surveys of clinician and laboratory practices in Australia and New Zealand.
Pathology
December 2024
Department of Immunology and Infectious Diseases, Sydney Children's Hospital, Randwick, NSW, Australia; Department of Microbiology and Infectious Diseases, Sydney Children's Hospital, Randwick, NSW, Australia; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.
Paediatric blood cultures are vital for the diagnosis of paediatric bloodstream infections. Quality of paediatric blood culture collection, processing and reporting depend on multiple factors, with a paucity of literature describing these in practice. We conducted separate surveys of clinicians and laboratory staff to assess quality standards and knowledge related to paediatric blood culture collection, analysis, and interpretation to identify improvement opportunities.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!